The AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care International) accreditation demonstrates a commitment to responsible animal care and use. The accreditation is widely recognized as a benchmark for excellence in animal welfare.
Our laboratory team has been trained and certified by biocrates to use the kit and provide metabolomics services to customers.
NUVISAN has received its official recognition with the BSFZ Seal from the “Bescheinigungsstelle Forschungszulage” (Certification Authority for Research Allowance). The BSFZ Seal, a vital government funding measure, marks a milestone, underscoring our ongoing pursuit of research excellence. This honor celebrates our commitment to innovative research, confirming our competence and dedication to driving innovation.
NUVISAN features state-of-the-art biosafety level 2 (BSL2) facilities dedicated to handling wildtype viruses and bacteria as well as viral vector systems.
NUVISAN has achieved a CyberVadis score of 856/1000, showcasing our dedication to Data Privacy, GDPR, Data Protection, Third Party Management, and Business Continuity. CyberVadis ensures a high standard of cybersecurity, reinforcing our commitment to a safe environment for drug discovery and development projects in the new year.
A certification proving our high level of performance in areas such as environmental stewardship, labor practices, ethics, and supply chain management.
A tax incentive program in France that is designed to encourage research and development (R&D) activities by companies.
Good Clinical Practices (GCP) is a set of internationally-accepted ethical and scientific quality standards for the design, conduct, monitoring, and reporting of clinical trials. GCP guidelines are intended to protect the rights, safety, and well-being of study participants, and to ensure the validity and reliability of the data generated from the trial.
We follow the GCP guidelines established by the Federal Institute for Drugs and Medical Devices (BfArM) and the U.S. Food and Drug Administration (FDA).
Good Distribution Practices (GDP) refer to the guidelines intended to ensure that medicinal products are stored, transported, and handled correctly, so that their quality and safety are maintained throughout the supply chain.
Good Laboratory Practices (GLP) are a set of guidelines and regulations that are intended to ensure the integrity and reliability of non-clinical laboratory studies. These studies are typically conducted on chemical or biological test articles, such as drugs or chemicals, and are used to support the safety evaluation of these products.
We follow the GLP guidelines established by the Federal Institute for Drugs and Medical Devices (BfArM), U.S. Food and Drug Administration (FDA), the Brazilian Health Regulatory Agency (ANVISA).
Good Manufacturing Practices (GMP) are a set of guidelines and regulations that are intended to ensure the quality and consistency of drugs for human or veterinary use throughout the manufacturing process.
We follow the GMP guidelines established by the Federal Institute for Drugs and Medical Devices (BfArM) and the U.S. Food and Drug Administration (FDA).
A "Certified Service Provider" (CSP) for their single cell sequencing technology is a company or laboratory that has been trained and certified by 10x Genomics to use their technology and provide sequencing services to customers. These providers have demonstrated a high level of technical expertise and are able to generate high-quality data using 10x Genomics' single cell sequencing products.